What is it about?
We report a case of severe acute TTP treated with plasma exchange and rituximab.
Featured Image
Why is it important?
Thrombotic thrombocytopenic purpura (TTP) is a rare severe disease that must be diagnosed and treated promptly for a successful outcome.
Perspectives
Early addition of rituximab for the treatment of our patient added benefits to achieve complete remission of the disease. This was the first report of rituximab use to treat TTP in Brazil. Nowadays, rituximab is part of the therapeutic arsenal to treat TTP.
Dr Cesar de Almeida-Neto
Faculty of Medicine, University of São Paulo
Read the Original
This page is a summary of: Púrpura trombocitopênica trombótica - remissão completa em paciente com mau prognóstico após tratamento com plasmaférese terapêutica e rituximabe, Revista Brasileira de Hematologia e Hemoterapia, February 2008, Elsevier,
DOI: 10.1590/s1516-84842008000100020.
You can read the full text:
Contributors
The following have contributed to this page
